Preceding infections, immune factors, and outcome in Guillain-Barré syndrome.
Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV; Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
Hadden RD, et al. Among authors: swan av.
Neurology. 2001 Mar 27;56(6):758-65. doi: 10.1212/wnl.56.6.758.
Neurology. 2001.
PMID: 11274311
Clinical Trial.